Hemoxygenase-1 Promotes Head and Neck Cancer Cell Viability

Hemoxygenase-1 Promotes Head and Neck Cancer Cell Viability

Head and neck squamous cell carcinoma (HNSCC) is a remarkably heterogeneous disease with around 50% mortality, a fact that has prompted researchers to try new approaches to improve patient survival. Hemoxygenase-1 (HO-1) is the rate-limiting step for heme degradation into carbon monoxide, free iron...

Full description

Bibliographic Details
Main Authors: Marilina Mascaró, Exequiel G. Alonso, Karen Schweitzer, Martín E. Rabassa, Jessica A. Carballido, Agustina Ibarra, Eliana N. Alonso, Vicente Bermúdez, Lucía Fernández Chavez, Georgina P. Coló, María Julia Ferronato, Pamela Pichel, Sergio Recio, Valentina Clemente, Maria Eugenia Fermento, María Marta Facchinetti, Alejandro C. Curino
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Antioxidants
Subjects:
hemoxygenase-1
nucleus
cancer
head and neck
Online Access:https://www.mdpi.com/2076-3921/11/10/2077

Internet

https://www.mdpi.com/2076-3921/11/10/2077

Similar Items